Largest Pharmaceutical Manufacturing Companies by Market Cap
Eli Lilly, founded in 1876, was the first company to mass-produce the polio vaccine and commercialize insulin — and it remains one of the most valuable pharmaceutical companies in the world. The pharmaceutical manufacturing sector spans the full value chain from drug discovery and R&D through clinical trials, regulatory approval, and large-scale production, with U.S. drugmakers accounting for roughly half of global biopharma R&D activity.
This category includes both traditional pharma and biotech companies, since many now operate as “biopharma” firms developing a range of therapeutic products. Among the top companies by market capitalization:
- Diabetes & Obesity: Novo Nordisk (founded 1923, headquartered in Bagsværd, Denmark) produces nearly half the world’s insulin and is behind blockbuster GLP-1 drugs Ozempic and Wegovy. Eli Lilly (NYSE: LLY) also leads in diabetes and obesity therapies.
- Oncology: Roche, founded in 1896 in Basel, Switzerland, derives roughly half its pharmaceutical sales from oncology products. Merck & Co. (NYSE: MRK) markets Keytruda, one of the most widely used cancer immunotherapies.
- Immunology: AbbVie (NYSE: ABBV), spun off from Abbott in 2013, anchors its portfolio around treatments like Humira, Skyrizi, and Rinvoq. Bristol-Myers Squibb (NYSE: BMY), formed in 1989, focuses on immunotherapy and autoimmune treatments.
- Vaccines: Sanofi, headquartered in Paris, is the world’s largest vaccine producer, delivering the first injectable polio vaccine. Pfizer (NYSE: PFE), founded in 1849, operates across more than 185 countries.
- Diversified pharma: Johnson & Johnson (NYSE: JNJ), established in 1886, combines pharmaceutical operations in oncology and immunology with medical technology. AstraZeneca (NASDAQ: AZN), based in Cambridge, UK, specializes in oncology, cardiovascular, and metabolic diseases. Novartis (NYSE: NVS), formed from the 1996 merger of Ciba-Geigy and Sandoz, operates in over 150 countries.
Geographically, U.S. companies dominate the top 50 pharmaceutical firms by market capitalization, followed by European companies — particularly from Switzerland, Denmark, France, and the UK. Japan is home to the largest pharma companies in Asia and represents the third-largest pharmaceutical market globally. For a broader view of the sector including medical devices, see our largest healthcare companies page.
Regulated brokerThe table below ranks the leading publicly traded pharmaceutical manufacturing companies by market capitalization, with live pricing and valuations updated throughout the trading day.
| Stock | Price | Change % | Marketcap |
|---|---|---|---|
Eli Lilly LLY | $1,110.86 | 1.12% | 990.60B |
Novo Nordisk NVO | $46.12 | 6.78% | 204.22B |
Johnson & Johnson JNJ | $230.55 | 0.95% | 554.98B |
AbbVie ABBV | $231.33 | 6.85% | 408.71B |
AstraZeneca AZN | $177.19 | 1.29% | 274.80B |
Merck MRK | $115.15 | 1.12% | 284.40B |
Novartis NVS | $149.05 | 1.34% | 284.40B |
Amgen AMGN | $343.94 | 1.88% | 185.63B |
Pfizer PFE | $25.18 | 0.14% | 143.48B |
Gilead Sciences GILD | $124.69 | 0.75% | 154.81B |
Sanofi SNY | $41.53 | 2.02% | 99.40B |
Bristol-Myers Squibb BMY | $54.49 | 0.90% | 111.26B |
GlaxoSmithKline GSK | $51.01 | 0.66% | 102.21B |
Biogen BIIB | $198.82 | 1.14% | 29.35B |
Grifols GRFS | $7.29 | 1.55% | 4.96B |
Organon OGN | $13.39 | 0.30% | 3.52B |
Amarin Corporation AMRN | $15.59 | 2.74% | 326.91M |
Scilex Holding SCLX | $6.99 | 6.43% | 49.16M |
Takeda Pharmaceutical TAK | $15.50 | 0.83% | 48.98B |
Haleon HLN | $8.82 | 1.62% | 38.91B |
Viatris VTRS | $15.35 | 0.16% | 17.87B |
Bausch Health BHC | $4.67 | 2.20% | 1.74B |
Zoetis ZTS | $76.53 | 2.77% | 32.08B |
Elanco ELAN | $24.18 | 0.19% | 12.07B |
Perrigo PRGO | $9.86 | 3.85% | 1.36B |
Dr. Reddy's RDY | $13.95 | 4.93% | 11.61B |
Amneal Pharmaceuticals AMRX | $16.26 | 0.28% | 5.19B |
Neurocrine Biosciences NBIX | $160.00 | 1.08% | 16.09B |
Alkermes ALKS | $46.33 | 2.98% | 7.72B |
Lantheus Holdings LNTH | $105.55 | 1.62% | 6.87B |
Indivior PLC INDV | $38.66 | 0.94% | 4.57B |
Emergent BioSolutions EBS | $8.05 | 0.63% | 415.35M |
Prestige Consumer Healthcare PBH | $45.61 | 2.90% | 2.16B |
Tilray TLRY | $4.67 | 1.22% | 564.51M |
Amphastar Pharmaceuticals AMPH | $18.51 | 1.59% | 816.16M |
Pacira Biosciences PCRX | $22.67 | 1.50% | 891.82M |
Supernus Pharmaceuticals SUPN | $44.28 | 0.23% | 2.57B |
HUTCHMED HCM | $9.98 | 2.92% | 1.72B |
Collegium Pharmaceutical COLL | $33.20 | 1.01% | 1.08B |
ANI Pharmaceuticals ANIP | $81.63 | 2.69% | 1.86B |
Organogenesis ORGO | $2.44 | 0.20% | 313.32M |
Alvotech ALVO | $3.77 | 3.95% | 1.27B |
Kiniksa Pharmaceuticals KNSA | $57.66 | 4.63% | 4.44B |
Ironwood Pharmaceuticals IRWD | $3.80 | 7.20% | 624.71M |
Esperion Therapeutics ESPR | $3.16 | 0.16% | 813.02M |
Evolus EOLS | $6.61 | 0.30% | 435.30M |
SIGA Technologies SIGA | $4.36 | 0.81% | 312.36M |
Akebia Therapeutics AKBA | $1.10 | 2.34% | 293.74M |
Harrow Health HROW | $43.27 | 0.92% | 1.61B |
Anika Therapeutics ANIK | $14.23 | 1.32% | 189.34M |
Kamada KMDA | $7.17 | 1.92% | 413.67M |
Lifecore Biomedical LFCR | $5.48 | 1.05% | 205.61M |
Assertio Therapeutics ASRT | $23.50 | 0.00% | 151.86M |
OrganiGram Holdings OGI | $0.974 | 0.97% | 137.13M |
Cronos Group CRON | $2.65 | 2.08% | 991.51M |
Rockwell Medical RMTI | $0.685 | 6.98% | 27.03M |
InterCure INCR | $1.09 | 16.83% | 62.01M |
Flagstar Bank, N.A. FLG | $14.97 | 2.15% | 6.24B |
Aquestive Therapeutics AQST | $4.81 | 2.12% | 603.42M |
Journey Medical DERM | $6.38 | 2.57% | 175.67M |
Alpha Teknova, Inc. TKNO | $4.95 | 5.53% | 265.39M |
Eton Pharmaceuticals, Inc. ETON | $32.38 | 0.32% | 886.83M |
Zhengye Biotechnology ZYBT | $0.715 | 4.72% | 33.87M |
BGM Group Ltd. BGM | $0.341 | 6.66% | 68.35M |
